Drug
Nanoxel
Nanoxel: highest development phase Phase 1, developed by Fresenius Kabi. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Fresenius Kabi
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nanoxel (Paclitaxel Nanoparticle formulation ) NCT00915369 | Phase 1 | Advanced Breast Cancer |
Latest
No recent events.
Follow Nanoxel on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.